This subtype represents between 2% and 4% of NSCLC patients. Outcomes are generally suboptimal for HER2-mutant disease for ...
WHEN Courtney Liniewski woke up in January 2022 to a loud bang in her head and found half her face drooping, she thought she was having a stroke. The 34-year-old tells Sun Health: “I remember ...
An analysis of 30 years of research has revealed a link between neck circumference and several serious health conditions ...
Katie Baber from Merthyr Tydfil 'didn’t have any of the typical symptoms' but her treatment journey provided hope ...
Data from a 2010 analysis, the Framingham Heart Study, a U.S. research project into heart disease that began in 1948, was ...
We used to accept a long, visible scar on the neck as the price of surgery. But now, with endoscope-assisted resections, we ...
Nanobiotix cash visibility into early 2028Transaction enables Nanobiotix development beyond key milestones in head and neck cancer and lung cancerFinancing establishes financial foundation toward self ...
Patients on a perioperative Keytruda regimen saw a 30 percent reduction in the risk of recurrence, progression, or death versus the control arm.
Company aims to shorten time frame to make PDS0101 available to patients with HPV16-positive head and neck cancer, projected to be the most dominant type of head and neck cancer in the US by mid 2030s ...
A DAD who struggled with “really bad back pain” for months broke his neck after stubbing his toe sent a “shockwave” up his ...
A dad had no idea that an incurable disease was 'eating away' at his bones, dismissing his symptoms as back pain. Then he ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback